Annual New York Lung Cancer Symposium 2010

The Sixth Annual New York Lung Cancer Symposium brings the key data from international oncology conferences to attending physicians. The importance of molecular pathology in diagnosis and treatment decision making will be emphasized, followed by other current topics of interest, such as maintenance therapy. The optimization of adjuvant therapy for patients with early-stage NSCLC and chemoradiation therapy for patients with locally advanced NSCLC will be reviewed. Management of patients with specific molecular defects such as EGFR mutations or the EML4-ALK fusion gene will also be discussed. Didactic lectures from lung cancer experts will set the stage for case-based panel discussions and opportunities for participants to interact with faculty. A multidisciplinary tumor board will discuss current advances and issues in locally advanced NSCLC. The symposium will also feature a case discussion session in which fellows can actively participate and thereby enhance their learning experience.